Cargando…

103 Genetic factors defining resistance and susceptibility to HIV/AIDS

One of the priorities for fundamental biomedical science is the discovery of the molecular-genetic basis of HIV pathogenesis. The progress in this area widens the possibilities for further improvement of HIV/AIDS prevention and therapy approaches. In this framework we have studied the population dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kofiadi, IA, Alexeev, LP, Khaitov, RM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAIDS Journal of Acquired Immune Deficiency Syndromes 2014
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149613/ http://dx.doi.org/10.1097/01.qai.0000446682.26851.0d

Ejemplares similares

101 Biomedical Prevention of HIV/AIDS in Russia
por: Karamov, E.V., et al.
Publicado: (2014)

102 HIV/AIDS vaccines in Russia: clinical trials and estimation of acceptance in population
por: Gudima, G., et al.
Publicado: (2014)

Peculiarities of the T Cell Immune Response in COVID-19
por: Kudlay, Dmitry, et al.
Publicado: (2022)

Effect of Macrolide Prophylactic Therapy on AIDS-Defining Conditions and HIV-Related Mortality
por: Pasayan, Mark Kristoffer, et al.
Publicado: (2017)

Antiviral Therapy of COVID-19
por: Gudima, Georgii, et al.
Publicado: (2023)

326. Is Antiretroviral Treatment Averting AIDS and non-AIDS Defining Malignancies in Colombia?
por: Martínez Buitrago, Ernesto, et al.
Publicado: (2019)

Clinical Characteristics and Outcomes of HIV-Infected Patients with Non-AIDS Defining Cancers in a National Institute Cancer in Mexico
por: Cavildo-Jerónimo, Denisse, et al.
Publicado: (2017)

S103. IS CANNABIS A RISK FACTOR FOR SUICIDE ATTEMPTS IN MEN AND WOMEN WITH PSYCHOTIC ILLNESS?
por: Waterreus, Anna, et al.
Publicado: (2018)

Non-AIDS-defining cancer mortality among people with AIDS in Italy
por: Zucchetto, Antonella, et al.
Publicado: (2010)

103. Empiric Antibiotic Susceptibility Using a Traditional vs. Syndromic Antibiogram-Implications for Antimicrobial Stewardship Programs
por: Klinker, Kenneth, et al.
Publicado: (2020)

103 Obesity Is Not Associated With Mortality In COVID-19 Pneumonia
por: McCormack, D., et al.
Publicado: (2021)

103. Evaluating The Appropriateness of Vaccine Administration in Patients with Splenectomy
por: Barsoum, Barbara, et al.
Publicado: (2022)

PS103. Search for biomarkers for ketamine response from changes of cytokines in the patients with treatment resistant depression
por: Su, Tung-Ping, et al.
Publicado: (2016)

2758. Clinical Significance and Antifungal Susceptibility Profile of 103 Clinical Scedosporium Species Complex and Lomentospora prolificans Isolated from NIH Hospitalized Patients
por: Czech, Mary, et al.
Publicado: (2023)

Influenza Pathogenesis in Genetically Defined Resistant and Susceptible Murine Strains  
por: Samet, Shelly J., et al.
Publicado: (2017)

103. Persistence on F/TDF for HIV Pre-exposure Prophylaxis: Insights from Real-world Evidence
por: Tao, Li, et al.
Publicado: (2020)

HIV/AIDS and Cryptococcosis in Costa Rica
por: Villalobos, Juan, et al.
Publicado: (2017)

FACTORS THAT IMPACT SUCCESSFUL AGING AMONG OLDER ADULTS LIVING WITH HIV/AIDS
por: Robinson, Erin, et al.
Publicado: (2022)

O10.3. EARLY BRAIN AND COGNITIVE DEVELOPMENT IN CHILDREN AT RISK FOR SCHIZOPHRENIA
por: Murphy, Veronica, et al.
Publicado: (2018)

10.3 GLIA-EXTRACELLULAR MATRIX INTERACTIONS IN THE PATHOPHYSIOLOGY OF SCHIZOPHRENIA AND BIPOLAR DISORDER
por: Berretta, Sabina, et al.
Publicado: (2018)

Host factors influencing susceptibility to HIV infection and AIDS progression
por: Lama, Juan, et al.
Publicado: (2007)

2265. The Changing Landscape of AIDS Defining CNS Infections in S. Alberta, Canada Over 30 Years
por: Lang, Raynell, et al.
Publicado: (2018)

Delay in anal cancer diagnosis as a non-AIDS-defining malignancy
por: Cohen, Justine, et al.
Publicado: (2010)

HIV Prevalence and Characteristics Among Patients With AIDS-Defining and Non–AIDS-Defining Cancers in a Tertiary Hospital in Kenya
por: Muturi, Diana, et al.
Publicado: (2023)

107 The modern methods for HIV/AIDS vaccine evaluation
por: Korobova, S.V., et al.
Publicado: (2014)

Enhanced Monitoring of Antiretroviral Resistance in Persons Living with HIV/AIDS
por: Gomez, James T., et al.
Publicado: (2015)

The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders
por: Theron, Annette J., et al.
Publicado: (2017)

1526. Hospitalized Patients with HIV – Defining the Population and the Impact of Barriers to Care
por: Hatlen, Timothy, et al.
Publicado: (2023)

Defining and Understanding Treatment Resistance in Obsessive-Compulsive Disorder
por: Dell’Osso, B.
Publicado: (2023)

F103. A META-ANALYSIS OF PERSONALITY TRAITS IN DUAL DIAGNOSIS PSYCHOSIS AND SUBSTANCE USE DISORDER
por: Oh, Hyeonju, et al.
Publicado: (2018)

103. Quantifying the Time Required to Administer OPAT Care: A Missed Opportunity to Compensate for the Value of ID
por: Schranz, Asher J, et al.
Publicado: (2023)

Analysis of trend in mortality due to HIV/AIDS-defining and non-HIV/AIDS defining illnesses according to sociodemographic characteristics, by Federative Unit and Brazil, 2000-2018
por: da Cunha, Ana Paula, et al.
Publicado: (2022)

2381. Ceftolozane/Tazobactam in the Treatment of Experimental Pseudomonas aeruginosa Pneumonia in Persistently Neutropenic Rabbits: Impact on Strains With Genetically Defined Resistance
por: Petraitis, Vidmantas, et al.
Publicado: (2018)

2246. Assessment of Factors Impacting Cervical Cancer Screening Rates Among Urban Women Living with HIV/AIDS
por: Reynoso-Vasquez, Nicole, et al.
Publicado: (2018)

Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study
por: Ismail, Nazir A., et al.
Publicado: (2018)

Spectrum of AIDS defining & non-AIDS defining malignancies in north India
por: Sachdeva, Ravinder Kaur, et al.
Publicado: (2016)

A13 HIV drug resistance over a decade of antiretroviral therapy scale-up for HIV/AIDS patients in Vietnam
por: Nguyen, L.A., et al.
Publicado: (2017)

A13 HIV drug resistance over a decade of antiretroviral therapy scale-up for HIV/AIDS patients in Vietnam
por: Nguyen, L.A., et al.
Publicado: (2017)

T233. DEFINING TREATMENT RESPONSE AND RESISTANCE IN FIRST EPISODE SCHIZOPHRENIA
por: Dempster, Kara, et al.
Publicado: (2018)

Women-specific HIV/AIDS services: identifying and defining the components of holistic service delivery for women living with HIV/AIDS
por: Carter, Allison J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_u4g5nlrip1nmbniqku4t3bchk2